| Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration V Margulis, SF Shariat, SF Matin, AM Kamat, R Zigeuner, E Kikuchi, ... Cancer 115 (6), 1224-1233, 2009 | 1129 | 2009 |
| BAP1 loss defines a new class of renal cell carcinoma S Peña-Llopis, S Vega-Rubín-de-Celis, A Liao, N Leng, A Pavía-Jiménez, ... Nature genetics 44 (7), 751-759, 2012 | 997 | 2012 |
| Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature G Lughezzani, M Burger, V Margulis, SF Matin, G Novara, M Roupret, ... European urology 62 (1), 100-114, 2012 | 439 | 2012 |
| Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes S Durinck, EW Stawiski, A Pavía-Jiménez, Z Modrusan, P Kapur, ... Nature genetics 47 (1), 13-21, 2015 | 365 | 2015 |
| Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma E Kikuchi, V Margulis, PI Karakiewicz, M Roscigno, S Mikami, Y Lotan, ... Journal of clinical oncology 27 (4), 612-618, 2009 | 307 | 2009 |
| Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma E Xylinas, M Rink, EK Cha, T Clozel, RK Lee, H Fajkovic, E Comploj, ... European urology 65 (1), 210-217, 2014 | 268 | 2014 |
| Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma SF Matin, V Margulis, A Kamat, CG Wood, HB Grossman, GA Brown, ... Cancer 116 (13), 3127-3134, 2010 | 245 | 2010 |
| Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration NJ Hellenthal, SF Shariat, V Margulis, PI Karakiewicz, M Roscigno, ... The Journal of urology 182 (3), 900-906, 2009 | 239 | 2009 |
| Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo KD Courtney, D Bezwada, T Mashimo, K Pichumani, V Vemireddy, ... Cell metabolism 28 (5), 793-800. e2, 2018 | 234 | 2018 |
| The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus NG Cost, SE Delacroix Jr, JP Sleeper, PJ Smith, RF Youssef, BF Chapin, ... European urology 59 (6), 912-918, 2011 | 232 | 2011 |
| Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? SH Culp, NM Tannir, EJ Abel, V Margulis, P Tamboli, SF Matin, CG Wood Cancer 116 (14), 3378-3388, 2010 | 229 | 2010 |
| Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma EK Cha, SF Shariat, M Kormaksson, G Novara, TF Chromecki, DS Scherr, ... European urology 61 (4), 818-825, 2012 | 222 | 2012 |
| Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases U Capitanio, SF Shariat, H Isbarn, A Weizer, M Remzi, M Roscigno, ... European urology 56 (1), 1-9, 2009 | 215 | 2009 |
| The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy TF Chromecki, EK Cha, H Fajkovic, V Margulis, G Novara, DS Scherr, ... European urology 61 (2), 245-253, 2012 | 212 | 2012 |
| Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract V Margulis, RF Youssef, PI Karakiewicz, Y Lotan, CG Wood, R Zigeuner, ... The Journal of urology 184 (2), 453-458, 2010 | 210 | 2010 |
| Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy M Roscigno, SF Shariat, V Margulis, P Karakiewicz, M Remzi, E Kikuchi, ... The Journal of urology 181 (6), 2482-2489, 2009 | 207 | 2009 |
| Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma V Margulis, SF Matin, N Tannir, P Tamboli, DA Swanson, E Jonasch, ... The Journal of urology 180 (1), 94-98, 2008 | 207 | 2008 |
| A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma S Sivanand, S Peña-Llopis, H Zhao, B Kucejova, P Spence, ... Science translational medicine 4 (137), 137ra75-137ra75, 2012 | 202 | 2012 |
| Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy JD Raman, CK Ng, DS Scherr, V Margulis, Y Lotan, K Bensalah, JJ Patard, ... European urology 57 (6), 1072-1079, 2010 | 199 | 2010 |
| Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients M Remzi, A Haitel, V Margulis, P Karakiewizc, F Montorsi, E Kikuchi, ... BJU international 103 (3), 307-311, 2009 | 191 | 2009 |
